The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Rima McLeod and Kamal El Bissati.
Connection Strength

4.275
  1. CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword. Vaccines (Basel). 2023 Sep 14; 11(9).
    View in: PubMed
    Score: 0.960
  2. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight. 2016 09 22; 1(15):e85955.
    View in: PubMed
    Score: 0.592
  3. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice. Vaccine. 2014 May 30; 32(26):3243-8.
    View in: PubMed
    Score: 0.500
  4. From TgO/GABA-AT, GABA, and T-263 Mutant to Conception of Toxoplasma. iScience. 2024 Jan 19; 27(1):108477.
    View in: PubMed
    Score: 0.243
  5. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Sci Rep. 2020 10 12; 10(1):16984.
    View in: PubMed
    Score: 0.196
  6. Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Front Cell Infect Microbiol. 2020; 10:203.
    View in: PubMed
    Score: 0.191
  7. Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep. 2020 Mar 23; 10(1):5512.
    View in: PubMed
    Score: 0.189
  8. Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect. 2018 Sep 27; 7(1):165.
    View in: PubMed
    Score: 0.170
  9. Protein nanovaccine confers robust immunity against Toxoplasma. NPJ Vaccines. 2017; 2:24.
    View in: PubMed
    Score: 0.158
  10. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep. 2016 07 14; 6:29179.
    View in: PubMed
    Score: 0.146
  11. Understanding Toxoplasmosis in the United States Through "Large Data" Analyses. Clin Infect Dis. 2016 08 15; 63(4):468-75.
    View in: PubMed
    Score: 0.146
  12. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14182-7.
    View in: PubMed
    Score: 0.111
  13. Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrob Agents Chemother. 2012 May; 56(5):2666-82.
    View in: PubMed
    Score: 0.108
  14. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-? and reduces parasite burden in HLA-B*0702 mice. Hum Immunol. 2012 Jan; 73(1):1-10.
    View in: PubMed
    Score: 0.105
  15. T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest. PLoS One. 2010 Nov 22; 5(11):e14057.
    View in: PubMed
    Score: 0.099
  16. High performance of a novel point-of-care blood test for Toxoplasma infection in women from diverse regions of Morocco. Emerg Microbes Infect. 2021 Dec; 10(1):1675-1682.
    View in: PubMed
    Score: 0.053
  17. Publisher Correction: Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Sci Rep. 2019 May 28; 9(1):8110.
    View in: PubMed
    Score: 0.045
  18. CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii. Front Cell Infect Microbiol. 2018; 8:352.
    View in: PubMed
    Score: 0.043
  19. Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies. PLoS Negl Trop Dis. 2018 08; 12(8):e0006536.
    View in: PubMed
    Score: 0.042
  20. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Sci Rep. 2017 09 13; 7(1):11496.
    View in: PubMed
    Score: 0.040
  21. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl Trop Dis. 2017 Jun; 11(6):e0005670.
    View in: PubMed
    Score: 0.039
  22. The Microbiome Activates CD4 T-cell-mediated Immunity to Compensate for Increased Intestinal Permeability. Cell Mol Gastroenterol Hepatol. 2017 Sep; 4(2):285-297.
    View in: PubMed
    Score: 0.039
  23. ?d Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice. Gastroenterology. 2015 Jun; 148(7):1417-26.
    View in: PubMed
    Score: 0.033
  24. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem. 2013 Jul; 8(7):1138-60.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.